SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is trending as investors rally around the company's optical interconnect technology, with strong bullish sentiment following a CFO interview that dismissed short-seller concerns and highlighted ongoing engagement with hyperscalers. The community is actively discussing the stock's massive trading volume and the potential for a significant re-rating as the company moves toward scaling production and securing major purchase orders.

Navitas Semiconductor Corp. engages in the development of ultra-efficient gallium nitride (GaN) semiconductors. Its GaN power ICs integrate GaN power with drive, control and protection to enable charging, power density, and energy savings for mobile, consumer, enterprise, eMobility and new energy markets. The company was founded by Daniel Kinzer, Nick Fichtenbaum, Gene Sheridan, and Jason Zhang on August 12, 2020 and is headquartered in Torrance, CA.

Navitas Semiconductor Corp

Navitas Semiconductor is experiencing significant upward momentum driven by intense retail interest and investor optimism regarding its gallium nitride (GaN) power chip technology, which is viewed as a critical component for future AI data center infrastructure. While bulls are encouraged by potential long-term partnerships and the company's role in next-gen power architectures, the community is actively debating whether this price action is a fundamental re-rating or a speculative short squeeze, with many participants warning of the company's current lack of profitability.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Sellas Life Sciences is currently trending as the community debates the implications of the AACR poster presentation for SLS009 and monitors for major clinical catalysts, including the 80th survival event in the REGAL Phase 3 trial. Discussions remain intensely focused on the balance between institutional accumulation, potential buyout speculation, and concerns over corporate communication, with vocal debates between long-term investors and short sellers regarding the company's valuation and clinical progress.

Opendoor Technologies, Inc. engages in the operation of buying, selling, and trading of residential properties online. The company was founded by Eric Wu on December 30, 2013, and is headquartered in Tempe, AZ.

Opendoor Technologies Inc

Opendoor Technologies is seeing intense community engagement as investors speculate on a major trend reversal, fueled by positive housing market data and optimism regarding the company's integrated transaction model. Traders are actively discussing the stock's short-squeeze potential, citing significant short interest and technical breakouts that have many comparing its growth trajectory to other high-beta market plays.

ProShares Trust II - ProShares Ultra Bloomberg Crude Oil 2x Shares

ProShares Ultra Bloomberg Crude Oil

The community is actively discussing ProShares Ultra Bloomberg Crude Oil (UCO) amidst extreme volatility in energy markets, fueled by fears of a supply crunch and a potential blockade in the Strait of Hormuz. Investors are intensely debating the impacts of geopolitical tensions on oil prices, with many questioning the efficacy of the ETF's leverage, while others argue that structural supply shortages could drive further upside.

Vistra Corp. is a holding company, which engages in the provision of electricity and power generation. It operates through the following segments: Retail, Texas, East, West, and Asset Closure. The Retail segment includes sale of electricity and natural gas to residential, commercial, and industrial customers. The Texas and East segments are involved in electricity generation, wholesale energy sales and purchases, commodity risk management activities, fuel production and fuel logistics management. The West segment represents the company's electricity generation operations in CAISO. The Asset Closure segment refers to the decommissioning and reclamation of retired plants and mines. The company was founded in 1882 and is headquartered in Irving, TX.

Vistra Corp

Vistra Corp is trending as investors react to a significant 20-year power purchase agreement with Meta Platforms to supply nuclear energy to support data center growth, fueling bullish momentum. Despite recent market volatility and retail investor skepticism regarding valuation, the community is actively debating the stock's role as a cornerstone of AI infrastructure and debating entry points amidst broader energy sector rotations.

Based Chad

CHAD is capturing significant community attention on the Base network, driven by its branding as the most globally recognizable internet meme and recent high-profile engagement from figures including Coinbase leadership. Investors are actively discussing the project's supply-shock mechanics, ongoing buyback initiatives, and upcoming developments like AAA gaming, with many proponents viewing it as a long-term accumulation play reminiscent of established legacy memecoins.

Back in 2011, long before “crypto Twitter”, NFTs, or VC-backed chains existed, users of the BitcoinTalk forum came up with a new currency - not to launch a network, but to make fun of btc.... and so: The first memecoin/memecurrency was born.  On May 23, 2011, a Something Awful poster cracked, “Has anyone called them buttcoins yet?”. It was sophomoric and perfect. Within weeks the gag metastasized into Buttcoin.org, a parody blog that described a “peer to peer butt” economy while cataloging mining fiascos, exchange blowups, and MLM-adjacent “innovations”.

Buttcoin

Buttcoin is surging in popularity as the community rallies around its 2011 origin as the first-ever cryptocurrency meme, positioning it as an authentic, culture-driven counterpart to Bitcoin. Investors are actively highlighting its deep historical lore and recent influx of high-conviction holdings as catalysts for its potential to reach significant market milestones.

Rigel Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. It discovers and develops novel, targeted drugs in the therapeutic areas of immunology, oncology and immune oncology. The firm focuses on intracellular signalling pathways and related targets that are critical to disease mechanisms. The company's products include Tavalisse, Fostamatinib and R835. Rigel Pharmaceuticals was founded by Donald G. Payan, James M. Gower, Thomas A. Raffin, Garry P. Nolan and Ronald B. Garren on June 14, 1996 and is headquartered in South San Francisco, CA.

Rigel Pharmaceuticals

Rigel Pharmaceuticals is trending as investors digest new clinical data from the ASH conference regarding its R289 IRAK1/4 inhibitor, which demonstrated red blood cell transfusion independence in heavily pre-treated MDS patients. The community is actively discussing the stock's strong commercial momentum and recent earnings performance, while speculating on the potential for strategic acquisitions or partnerships given the company's profitable status and pipeline progression.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending due to widespread speculation that a former company executive, Houman Hemmati, is a leading candidate for the FDA's top biologics regulator position. The community is actively discussing how this potential appointment, combined with the company's robust clinical trial data, could accelerate the approval process for their DMD therapy and trigger a significant upward valuation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

DOC or NHI: Which Is the Better Value Stock Right Now?

DOC vs. NHI: Which Stock Is the Better Value Option?

Key Reasons to Add Healthpeak Properties Stock to Your Portfolio Now

 DOC gains from strong lab demand and rising senior healthcare needs, supported by portfolio repositioning and solid balance sheet strength.

Healthpeak Properties Announces Dates of First Quarter 2026 Earnings Release, Conference Call, and Webcast

Healthpeak Properties, Inc. (NYSE: DOC), a leading owner, operator, and developer of real estate for healthcare discovery and delivery, is scheduled to report first quarter 2026 financial results...

Healthpeak Properties Declares Monthly Common Stock Cash Dividends for the Second Quarter of 2026

Healthpeak Properties, Inc. (NYSE: DOC), a leading owner, operator, and developer of real estate for healthcare discovery and delivery, announced that on April 6, 2026, its Board of Directors declared a monthly common stock cash dividend of $0.10167 per share for the second quarter of 2026, payable...

Healthpeak Properties Closes New $400 Million Delayed-Draw Term Loan Facility

Healthpeak Properties, Inc. (NYSE: DOC) (Healthpeak), a leading owner, operator, and developer of real estate for healthcare discovery and delivery, announced today that it has closed on a new $400 million unsecured delayed-draw term loan facility (Term Loan). This new term loan enhances our...

Healthpeak Properties and Janus Living Announce Closing of Janus Living Initial Public Offering

Healthpeak Properties, Inc. (NYSE: DOC) (Healthpeak) and Janus Living, Inc. (NYSE: JAN) (Janus Living) announced today that Janus Living has completed its initial public offering of 48,300,000 shares...

Healthpeak Properties and Janus Living Announce Pricing of Upsized $840 Million Janus Living Initial Public Offering

Healthpeak Properties, Inc. (NYSE: DOC) (Healthpeak) and Janus Living, Inc. (Janus Living) announced the pricing of Janus Livings upsized initial public offering (IPO) of 42,000,000 shares of Janus...

Healthpeak & Janus Living Announce Launch of Janus Living IPO

DOC launches Janus Living IPO of 37M shares at $18-$20, retaining ~85% stake post-IPO offering in its senior housing REIT spinoff.

Healthpeak Properties and Janus Living Announce Launch of Janus Living Initial Public Offering

Healthpeak Properties, Inc. (NYSE: DOC) (Healthpeak) and Janus Living, Inc. (Janus Living), announced today that Janus Living has launched its initial public offering of 37,000,000 shares of its...

Welltower (WELL) Down 1.2% Since Last Earnings Report: Can It Rebound?

Welltower (WELL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Healthpeak Properties, Inc. is a Standard & Poor’s 500 company, which engages in acquiring, developing, owning, leasing, and managing healthcare real estate across the United States. It operates through the following segments: Lab, Outpatient Medical, Continuing Care Retirement Community (CCRC), and Other Non-Reportable. The Lab segment refers to lab properties, which contain laboratory and office space. The Outpatient Medical segment includes outpatient medical buildings and hospitals. The CCRC segment deals with retirement communities that include independent living, assisted living, memory care, and skilled nursing units. The Other Non-Reportable segment consists of an unconsolidated joint venture with a sovereign wealth fund that owns 19 senior housing assets and loans receivable. The company was founded in 1985 and is headquartered in Denver, CO.

DOC
Physicians Realty Trust

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest DOC News

DOCPhysicians Realty Trust